Andreana Holowyj, PhD, MSCI
Andreana Holowyj, PhD, MSCI
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
Appendix Cancer
Appendiceal Cancer
Appendiceal Neoplasms
Appendiceal Mucinous Neoplasm
Appendiceal Adenocarcinoma
Appendiceal Carcinoid Tumor
Appendiceal Neoplasm Malignant Secondary
Appendix Adenocarcinoma
Appendix Mucinous Neoplasm
Appendix Tumor
Appendix Cancer Metastatic
Appendix NET
Low-Grade Appendix Mucinous Neoplasm
High Grade Appendix Mucinous Neoplasm
High Grade Appendix Mucinous Adenocarcinoma
Genetic profiling
Retrospective tissue procurement
The Genetics of Appendix Cancer (GAP) Study aims to analyze hereditary factors, tumor characteristics and clinical features/outcomes among adults diagnosed with appendix cancer and their biological parents. Patients are recruited at any time after a diagnosis of appendix cancer and followed for up to 6 years after study enrollment. This cohort is enriched by robust biospecimens and data collections.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 700 participants |
| Official Title : | Genetics of Appendix Cancer: The GAP Study |
| Actual Study Start Date : | 2022-11-11 |
| Estimated Primary Completion Date : | 2032-11 |
| Estimated Study Completion Date : | 2034-11 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232